Dahm P, Wilt T, Franco J V. NHS recommendations on prostate cancer screening are valid BMJ 2026; 392 :s10 doi:10.1136/bmj.s10

Yoo SGK, Teufel F, Theilmann M, Si Y, Toure EA, Aryal K, Bärnighausen T, Bait A, Barreto M, Bovet P, Brant LCC, Cuschieri S, Damasceno A, Farzadfar F, Fawwad A, Geldsetzer P, Hambleton IR, Houehanou C, Howitt C, J Rgensen J, González-Rivas JP, Labadarios D, Marcus M, Martins J, Mwalim O, Nieto-Martínez R, Odili AN, Orazumbekova B, Perman G, Quesnel-Crooks S, Moghaddam SS, Sewpal R, Sousa-Uva M, Sulola MA, Venkataraman K, Vollmer S, Xueling S, Atun R, Banegas JR, Franco JVA, Arnott C, Chandiwana N, Huffman MD, Davies J, Ali MK, Flood D, Manne-Goehler J. GLP-1 receptor agonists for obesity: eligibility across 99 countries. Lancet Diabetes Endocrinol. 2026 Feb;14(2):105-108.